Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Fitzgerald

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Mechanisms of acute lumen gain following cutting balloon angioplasty in calcified and noncalcified lesions: an intravascular ultrasound studyHiroyuki Okura, Motoya Hayase, Shinichi Shimodozono, et al.
Circulation|March 3, 2010
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trialHertzel C Gerstein, Robert E Ratner, Christopher P Cannon, et al.
The American Journal of Cardiology|May 12, 2007
Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stentAlexandre Abizaid, Alexandra J Lansky, Peter J Fitzgerald, et al.
Cardiovascular Diabetology|August 21, 2015
Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromesKozo Okada, Kiyoshi Hibi, Masaomi Gohbara, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2010
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trialsKatsuhisa Waseda, Takao Hasegawa, Junya Ako, et al.
JACC. Cardiovascular Interventions|June 23, 2009
A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study)Tsutomu Takagi, Hiroyuki Okura, Yoshiki Kobayashi, et al.
Circulation|October 3, 2002
7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)Toru Kataoka, Eberhard Grube, Yasuhiro Honda, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
ESC Heart Failure|January 8, 2019
Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure: results from the Carmel studyOsami Kawarada, Teruyoshi Kume, Kan Zen, et al.
The American Journal of Cardiology|August 9, 2006
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)Yoshihiro Tsuchiya, Alexandra J Lansky, Ricardo A Costa, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Mechanisms of acute lumen gain following cutting balloon angioplasty in calcified and noncalcified lesions: an intravascular ultrasound studyHiroyuki Okura, Motoya Hayase, Shinichi Shimodozono, et al.
Circulation|March 3, 2010
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trialHertzel C Gerstein, Robert E Ratner, Christopher P Cannon, et al.
The American Journal of Cardiology|May 12, 2007
Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stentAlexandre Abizaid, Alexandra J Lansky, Peter J Fitzgerald, et al.
Cardiovascular Diabetology|August 21, 2015
Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromesKozo Okada, Kiyoshi Hibi, Masaomi Gohbara, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2010
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trialsKatsuhisa Waseda, Takao Hasegawa, Junya Ako, et al.
JACC. Cardiovascular Interventions|June 23, 2009
A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study)Tsutomu Takagi, Hiroyuki Okura, Yoshiki Kobayashi, et al.
Circulation|October 3, 2002
7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)Toru Kataoka, Eberhard Grube, Yasuhiro Honda, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
ESC Heart Failure|January 8, 2019
Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure: results from the Carmel studyOsami Kawarada, Teruyoshi Kume, Kan Zen, et al.
The American Journal of Cardiology|August 9, 2006
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)Yoshihiro Tsuchiya, Alexandra J Lansky, Ricardo A Costa, et al.
Pageof 21